Ryo Ikoma1, Junichi Ishitoya2, Yasunori Sakuma2, Mariko Hirama2, Osamu Shiono2, Masanori Komatsu3, Nobuhiko Oridate3. 1. Department of Otolaryngology, Yokohama City University Medical Center, Urafune-cho 4-57, Minami-ku, Yokohama 232-0024, Japan. Electronic address: ikoma-r@minamikyousai.jp. 2. Department of Otolaryngology, Yokohama City University Medical Center, Urafune-cho 4-57, Minami-ku, Yokohama 232-0024, Japan. 3. Department of Biology and Function in Head and Neck, Yokohama City University Graduate School of Medicine, Fukuura 3-9, Kanazawa-ku, Yokohama 236-0004, Japan.
Abstract
OBJECTIVE: To investigate the clinical factors associated with temporary facial nerve dysfunction (TFND) following surgery for benign parotid gland tumors. METHODS: We reviewed the records of 175 patients with benign parotid gland tumors who underwent partial parotidectomy at Yokohama City University Medical Center in Japan. TFND was found in 33 patients (18.9%). We used two hypothetical lines in magnetic resonance imaging (MRI) images to define the tumor location (upper/lower or anterior/posterior) in the parotid gland. We then studied the associations of TFND with the following clinical factors: patient age, tumor size, histopathological diagnosis, and the location of the tumor within the parotid gland (superficial lobe/deep lobe; upper part/lower part; and anterior part/posterior part). RESULTS: Tumors located in the upper parts, anterior parts or the deep lobes of the parotid gland had statistically higher incidences of TFND compared with tumors located in the lower parts, posterior parts or the superficial lobe (P<0.001, <0.001, <0.01, respectively). The odds ratio for the risk of TFND was significantly high if tumors were located in the upper parts, the anterior parts or the deep lobes with stepwise multivariate regression analysis. The other factors, including patient's age, tumor size, histopathology of the tumor, and inadequate surgeon's experience, were not apparent risks for TFND. CONCLUSIONS: Parotid gland tumors located in the upper parts, the anterior parts or the deep lobes had a higher risk of TFND. The two hypothetical lines we used were shown to be useful to define the tumor location, eventually the risk of TFND.
OBJECTIVE: To investigate the clinical factors associated with temporary facial nerve dysfunction (TFND) following surgery for benign parotid gland tumors. METHODS: We reviewed the records of 175 patients with benign parotid gland tumors who underwent partial parotidectomy at Yokohama City University Medical Center in Japan. TFND was found in 33 patients (18.9%). We used two hypothetical lines in magnetic resonance imaging (MRI) images to define the tumor location (upper/lower or anterior/posterior) in the parotid gland. We then studied the associations of TFND with the following clinical factors: patient age, tumor size, histopathological diagnosis, and the location of the tumor within the parotid gland (superficial lobe/deep lobe; upper part/lower part; and anterior part/posterior part). RESULTS:Tumors located in the upper parts, anterior parts or the deep lobes of the parotid gland had statistically higher incidences of TFND compared with tumors located in the lower parts, posterior parts or the superficial lobe (P<0.001, <0.001, <0.01, respectively). The odds ratio for the risk of TFND was significantly high if tumors were located in the upper parts, the anterior parts or the deep lobes with stepwise multivariate regression analysis. The other factors, including patient's age, tumor size, histopathology of the tumor, and inadequate surgeon's experience, were not apparent risks for TFND. CONCLUSIONS:Parotid gland tumors located in the upper parts, the anterior parts or the deep lobes had a higher risk of TFND. The two hypothetical lines we used were shown to be useful to define the tumor location, eventually the risk of TFND.
Authors: Agnaldo J Graciano; Carlos A Fischer; Guilherme V Coelho; José H Steck; Jorge R Paschoal; Carlos T Chone Journal: Eur Arch Otorhinolaryngol Date: 2018-09-19 Impact factor: 2.503
Authors: Petar Stankovic; Jan Wittlinger; Nina Timmesfeld; Stephan Hoch Stephan; Robert Georgiew; Thomas Günzel; Afshin Teymoortash; Thomas Wilhelm Journal: Eur Arch Otorhinolaryngol Date: 2018-04-20 Impact factor: 2.503
Authors: Abdulwahid M Salih; Hiwa O Baba; Yadgar A Saeed; Aso S Muhialdeen; Fahmi H Kakamad; Shvan H Mohammed; Zuhair D Hammood; Karzan M Salih; Rawezh Q Salih; Dahat A Hussein; Hunar A Hassan Journal: J Int Med Res Date: 2022-07 Impact factor: 1.573
Authors: John Maddalozzo; Douglas R Johnston; Andre Isaac; Bharat Bhushan; Jeffrey C Rastatter Journal: Laryngoscope Investig Otolaryngol Date: 2019-08-19